Drug Profile
RS 83277
Latest Information Update: 12 Jun 2001
Price :
$50
*
At a glance
- Originator Unknown
- Class Cytostatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 12 Jun 2001 No-Development-Reported for Cancer (Unknown route)